Don’t miss the latest developments in business and finance.

image

Dostarlimab cancer drug

About Dostarlimab cancer drug

Facebook IconLinkedIN Icon

What is Dostarlimab?

What is Dostarlimab?
 
For the first time in history, Dostarlimab, a monoclonal antibody drug, has been termed as a 'potential' cure for cancer.
 
A clinical trial conducted by the US-based Memorial Sloan Kettering Cancer Center in 2022 discovered that all 18 rectal cancer patients found that their cancer had disappeared within six months after receiving an experimental treatment of this promising breakthrough medication. Participants of the trial were given at least nine doses of the drug every three weeks for six months.
After the completion of the duration, all patients showed a clinical complete response with no signs of the tumour. The treatment was followed by chemotherapy, radiation sessions, endoscopy, biopsy, and invasive surgery.
 
How does it work?
 
Dostarlimab, sold under the brand name Jemperli and marketed by GlaxoSmithKline (GSK), is an immunotherapy drug with laboratory-produced molecules and it acts as substitute antibodies in the human body. This medication blocks cancer-causing cells that help the immune system to identify and act against such cells and tissues.
 
Dostarlimab was approved for medical use in the United States and the European Union in April 2021.
 
According to researchers, Dostarlimab is used in the treatment of endometrial cancer and is an effective treatment for advanced deficient Mismatch Repair (dMMR) solid tumours.
 
Usage and side effects
 
Dostarlimab is in a liquid (solution) form, which is injected into a vein over 30 minutes. The drug is given once every three weeks for four cycles, and then once every six weeks, according to the doctor's recommendations. The doctor may permanently or temporarily reduce or stop the Dostarlimab-led treatment, depending on the patient's response to the medication and side effects.
 
Only patients with the genetic property of mismatch repair (MMR) deficiency, can receive the treatment of this drug.
 
The most common side effects of Dostarlimab include fatigue, nausea, vomiting, joint and chest pain, itching, fever, anaemia, diarrhoea, constipation and hypothyroidism.
 
Cost of cancer drug
 
According to New York Times, the estimated cost of the Dostarlimab drug is nearly $11,000 or Rs 8.55 lakh per dose.

Here are the latest news from Business Standard

Latest News

IND vs AUS LIVE CRICKET SCORE: Bumrah says Rohit opted to rest himself. India make two changes in India's Playing 11. Prasidh replaces Akash in India's XI

Updated On: 03 Jan 2025 | 5:41 AM IST

While the reports were flooding in a day before that Rohit dropped himself from India's Playing 11, stand-in captain Jasprit Bumrah revealed at the toss on Friday that Rohit thought about the team

Updated On: 03 Jan 2025 | 5:08 AM IST

India are without their regular captain Rohit Sharma, who dropped himself for the fifth Test. India made two changes in their Playing 11

Updated On: 03 Jan 2025 | 4:51 AM IST

Pitch report by Sunil Gavaskar: "There is a lot of grass on the pitch. The sun is not out and it is very overcast. The new ball will not be easy for the batters"

Updated On: 03 Jan 2025 | 4:47 AM IST

Though captain dropping himself has happened for the first time in India's cricket history, here are six notable examples in cricketing folklore.

Updated On: 03 Jan 2025 | 4:37 AM IST

The higher revenue is on account of changed policy in Andhra Pradesh, new launches and a higher share of the premium segment in the product mix

Updated On: 03 Jan 2025 | 12:39 AM IST

Account for over 41% of visas along with Cognizant, HCLTech

Updated On: 03 Jan 2025 | 12:38 AM IST

December is usually a tepid month for IPOs as securing foreign portfolio investors (FPI) support is a challenge due to the holiday season

Updated On: 03 Jan 2025 | 12:32 AM IST

The much-anticipated interest rate cut cycle may be delayed, but experts believe the Reserve Bank of India (RBI) will reduce rates in 2025

Updated On: 03 Jan 2025 | 12:27 AM IST

Eicher Motors said it has launched some category-defining motorcycles through the year and it is encouraging to see the response to its recently launched motorcycles both in India and int'l markets.

Updated On: 03 Jan 2025 | 12:16 AM IST

The aviation analytics firm analyzes more than 25 million data points from 600-plus sources each day to determine whether airlines are meeting their scheduled arrival times

Updated On: 03 Jan 2025 | 12:10 AM IST

Videos taken by witnesses inside and outside the hotel showed the vehicle exploding and flames pouring out of it, as it sat outside the hotel

Updated On: 03 Jan 2025 | 12:03 AM IST

The budgetary allocation for this scheme is Rs 25,938 crore

Updated On: 02 Jan 2025 | 11:46 PM IST

Hundreds of thousands of displaced people are huddling in Muwasi in damp winter weather

Updated On: 02 Jan 2025 | 11:46 PM IST

Capital markets regulator Sebi on Thursday is offering a range of free tools and resources on its investor website and the 'Saarthi' App as part of its investor education initiatives.

Updated On: 02 Jan 2025 | 11:43 PM IST

The FBI is investigating the attack as an act of terrorism and said it does not believe the suspect acted alone

Updated On: 02 Jan 2025 | 11:37 PM IST

He also highlighted that there has been tremendous growth in youth employment and a reduction in unemployment rates, as evidenced by the latest PLFS

Updated On: 02 Jan 2025 | 11:36 PM IST

Data sourced from the MGNREGA website showed that 21.58 million households sought work under the scheme in December

Updated On: 02 Jan 2025 | 11:31 PM IST

The FBI now says that the pickup truck driver responsible for a deadly rampage in New Orleans acted alone.

Updated On: 02 Jan 2025 | 11:31 PM IST

Before the prayer meet, the family of the former PM would also hold a 'bhog' of the 'Akhand Path' kept in the memory of Singh at their 3, Motilal Nehru Marg residence

Updated On: 02 Jan 2025 | 11:25 PM IST

No More Data